Antagonist antibody to NPR1, REGN-NPR17544 (baloncibart), increases blood pressure and plasma volume

Hypotension and hypovolemia cause morbidity across many clinical disorders, yet pharmacologic options are limited. REGN-NPR1 7544 (REGN7544/baloncibart), a first-in-class monoclonal antibody, allosterically antagonizes natriuretic peptide receptor 1 (NPR1), a membrane guanylyl cyclase activated by atrial natriuretic peptide (ANP) and brain natriuretic peptide to promote vasorelaxation and natriuresis. REGN-NPR1 7544 bound human and cynomolgus monkey NPR1 with nanomolar affinity, increased systolic blood pressure (SBP) in NPR1 Hu/Hu mice by 10–15 mmHg for up to 28 days, corrected severe hypotension in ANP-overexpressing mice, and inhibited ANP-induced mesenteric vessel relaxation. In monkeys, SBP increased by 15–20 mmHg, with biomarkers consistent with plasma volume expansion. In a randomized, placebo-controlled, phase 1 single-ascending-dose study in healthy adults (N = 80), doses ≥ 100 mg were generally well-tolerated, producing sustained 5–10 mmHg SBP increases and biomarker signals consistent with volume expansion. These data implicate tonic NPR1 signaling in human blood pressure and volume regulation, supporting REGN-NPR1 7544 as a candidate for hypotension and hypovolemia.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-10779601/v1
Primary Topic
Cardiovascular, Neuropeptides, and Oxidative Stress Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Antagonist antibody to NPR1, REGN-NPR17544 (baloncibart), increases blood pressure and plasma volume

Ashique Rafique, Pamela Krueger, Benjamin A. Olenchock, Lori G. Morton et al.
6 links
Research Square
Cardiovascular, Neuropeptides, and Oxidative Stress Research
preprint

Antagonist antibody to NPR1, REGN-NPR17544 (baloncibart), increases blood pressure and plasma volume

Ashique Rafique, Pamela Krueger, Benjamin A. Olenchock, Lori G. Morton, Annabel Romero Hernandez, Andre Jo-Hao Ho, Justin Torello, Akshay Shekhar, Mazhar Thakur, Sai Kiran Sharma, Dipti K. Pawaskar, Elena S. Garnova, Hana A. Itani, Hao Pan, Kishor B. Devalaraja-Narashimha, Raji Swamy, Jee Kim, Gary A. Herman, George D. Yancopoulos, Ethan P. Marin, Katie Tuckwell, Mao Wang, Andrew J. Murphy, Chris Wynne, Emily Redington, Tammy Huang, Ximei Jin, Xia Mao, Mohsin Ahmed, Meng Xu, Matthew Franklin, Michael Dunn, Xiping Cheng, William Olson, Kevin Guley, Dongqin Zhang
preprint en

Abstract

Hypotension and hypovolemia cause morbidity across many clinical disorders, yet pharmacologic options are limited. REGN-NPR1 7544 (REGN7544/baloncibart), a first-in-class monoclonal antibody, allosterically antagonizes natriuretic peptide receptor 1 (NPR1), a membrane guanylyl cyclase activated by atrial natriuretic peptide (ANP) and brain natriuretic peptide to promote vasorelaxation and natriuresis. REGN-NPR1 7544 bound human and cynomolgus monkey NPR1 with nanomolar affinity, increased systolic blood pressure (SBP) in NPR1 Hu/Hu mice by 10–15 mmHg for up to 28 days, corrected severe hypotension in ANP-overexpressing mice, and inhibited ANP-induced mesenteric vessel relaxation. In monkeys, SBP increased by 15–20 mmHg, with biomarkers consistent with plasma volume expansion. In a randomized, placebo-controlled, phase 1 single-ascending-dose study in healthy adults (N = 80), doses ≥ 100 mg were generally well-tolerated, producing sustained 5–10 mmHg SBP increases and biomarker signals consistent with volume expansion. These data implicate tonic NPR1 signaling in human blood pressure and volume regulation, supporting REGN-NPR1 7544 as a candidate for hypotension and hypovolemia.

Research Square
Regeneron (United States) (US), New Zealand Clinical Research (NZ)
Good health and well-being
Cardiovascular, Neuropeptides, and Oxidative Stress Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon